Sitravatinib in combination with nivolumab plus ipilimumab in patients with advanced clear cell renal cell carcinoma: a phase 1 trial.
Msaouel P, Yu K, Yuan Y, Chen J, Yan X, Karki M, Duan F, Sheth RA, Rao P, Sircar K, Shah AY, Zurita AJ, Genovese G, Li M, Yeh CC, Dang M, Han G, Chu Y, Hallin M, Olson P, Yang R, Slavin D, Der-Torossian H, Chin CD, Tannir NM, Wang L, Gao J.
Msaouel P, et al. Among authors: han g.
Nat Commun. 2025 Jan 10;16(1):578. doi: 10.1038/s41467-024-55642-8.
Nat Commun. 2025.
PMID: 39794332
Clinical Trial.